Immunotherapy Could Fill Unmet Need in Leptomeningeal Metastases ...Middle East

Medscape - News
Immunotherapy with pembrolizumab holds promise for improving the generally dismal outlook in patients with leptomeningeal metastases, a phase 2 trial suggests. Medscape Medical News

Hence then, the article about immunotherapy could fill unmet need in leptomeningeal metastases was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy Could Fill Unmet Need in Leptomeningeal Metastases )

Apple Storegoogle play

Last updated :

Also on site :